It is also worth noting that while laminitis is already well-associated with atherosclerotic markers, HSP90 inhibitors may reduce atherosclerosis during diabetes (55) and restore glucocorticoid sensitivity during Cushing's disease (56). Here, HSP90AB1 is linked to diabetes mellitus.